Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Tissue kallikrein (KLK1) expression is up-regulated in human diabetic kidney tissue and induced by high glucose (HG) in human proximal tubular epithelial cells (PTEC). Since the kallikrein-kinin system (KKS) has been linked to cellular inflammatory process in many diseases, it is likely that KLK1 expression may mediate the inflammatory process during the development of diabetic nephropathy. In this study, we explored the role of KLK1 in tubular pro-inflammatory responses under the diabetic milieu. Recombinant KLK1 stimulated the production of inflammatory cytokines in PTEC via the activation of p42/44 and p38 MAPK signaling pathways. Molecular knockdown of endogenous KLK1 expression by siRNA transfection in PTEC attenuated advanced glycation end-products (AGE)-induced IL-8 and ICAM-1 productions in vitro. Interestingly, exposure of PTEC to KLK1 induced the expression of protease-activated receptors (PARs). There was a 2.9-fold increase in PAR-4, 1.4-fold increase in PAR-1 and 1.2-fold increase in PAR-2 mRNA levels. Activation of PAR-4 by a selective agonist was found to elicit the pro-inflammatory and pro-fibrotic phenotypes in PTEC while blockade of the receptor by specific antagonist attenuated high glucose-induced IL-6, CCL-2, CTGF and collagen IV expression. Calcium mobilization by the PAR-4 agonist in PTEC was desensitized by pretreatment with KLK1. Consistent with these in vitro findings, there was a markedly up-regulation of tubular PAR-4 expression in human diabetic renal cortical tissues. Together, these results suggest that up-regulation of KLK1 in tubular epithelial cells may mediate pro-inflammatory pathway and PAR activation during diabetic nephropathy and provide a new therapeutic target for further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A previous study suggested that Klk1 may induce inflammatory cytokines in human RTECs, at least in vitro [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
In the citing paper
“Additionally, Klk1 activates protease-activated receptors (PAR) such as PAR4 to trigger the release of inflammatory mediators from RTEC [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
In the citing paper
“Klk1-mediated activation of PAR4 induces cytokine production and prevents apoptosis in RTEC, known as the bradykinin-independent pathway [37].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744 · cited 1×
“In most studies, KLK1 targets B2R via the formation of bradykinin (BK) [49] and we previously demonstrated this phenomenon in HG stimulated PTEC [9] although KLK1 was recently shown to directly activate B2R in the absence of kininogen both in vitro [50] and in vivo [51] in other cell types.”
BackgroundCellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078 · cited 3×
“The increased PAR-4 expression after KLK1 incubation is consistent with the irreversible nature of PAR activation, in which the activating protease cleaves the extracellular N terminus to expose the tethered ligand, such that a fresh supply of the receptor is required to sustain the action of its agonist [20].”
BackgroundInflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072 · cited 2×
“Increased production of reactive oxygen species, pro-inflammatory cytokines and growth factors by resident and infiltrating cells are associated with the development of tubulointerstitial lesions in both clinical and experimental models of DN [3,4,34].”
BackgroundThe Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932 · cited 2×
“Inflammatory cytokines, mainly interleukin 1(IL-1), interleukin 6 (IL-6), interleukin 8 (IL-8) and tumor necrosis factor a (TNFa) are involved in the development of and progression to interstitial fibrosis in both diabetic patients and experimental models [4,5].”
BackgroundDiverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652 · cited 1×
“In addition to cytokine production, induction of growth factors, such as insulin-like growth factor 1 (IGF-1), hepatocyte growth factor (HGF), transforming growth factor b (TGFb) and connective tissue growth factor (CTGF) in proximal tubules enhances the activation and proliferation of myofibroblasts and collagen depo…”
BackgroundSelf-citationThe proximal tubule in the pathophysiology of the diabetic kidney
Vallon, V. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00809.2010 · Cited by 395 · cited 1×
“Tubulointerstitial inflammation is a critical process in the development of diabetic nephropathy [1,3,5].”
BackgroundPatel, V., Li, L., Cobo-Stark, P., Shao, X., Somlo, S., Lin, F., & Igarashi, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn045 · Cited by 327 · cited 1×
“induced diabetic mice [35], the role of KKS in inflammatory pathways leading to DN is still controversial.”
BackgroundChung, A. C. K., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050510 · Cited by 268 · cited 1×
“Up-regulation of intercellular adhesion molecule 1 (ICAM-1) and chemokine (C-C motif) ligand 2 (CCL-2) leads to inflammatory cell recruitment and activation in the diabetic kidney [6].”
BackgroundSelf-citationImpaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Russo, L. M., Sandoval, R. M., Campos, S. B., Molitoris, B. A., Comper, W. D., & Brown, D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050503 · Cited by 261 · cited 1×
“tubules have been identified to be responsible for the change in urinary albumin excretion, which is independent of glomerular permeability changes during the very early stage of DN [13].”
BackgroundProteinase-activated Receptors, Targets for Kallikrein Signaling
Oikonomopoulou, K., Hansen, K. K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G. S., Bunnett, N. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513138200 · Cited by 247 · cited 12×
“PARs staining were scored on 0–5 scoring system (0= no cortical staining; 1 =, 10% cortical staining; 2 = 10–20% cortical staining; 3 = 20–40% cortical staining; 4 = 40–60% cortical staining; 5 =.60% cortical staining) and were quantified by Image Pro Plus 6.0 software PLOS ONE | www.plosone.org 6 February 2014 | Volu…”
BackgroundInfluentialChambers, R. C., Leoni, P., Blanc-Brude, O. P., Wembridge, D. E., & Laurent, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003188200 · Cited by 233
Activation of Proteinase-Activated Receptor-2 by Human Kallikrein-Related Peptidases
Stefansson, K., Brattsand, M., Roosterman, D., Kempkes, C., Bocheva, G., Steinhoff, M., & Egelrud, T. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700965 · Cited by 195 · cited 1×
“PAR-2 is a potent pro-inflammatory mediator in keratinocytes [40] and kidney cells [33,41,42].”
BackgroundTherapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation
Kelso, E. B., Lockhart, J. C., Hembrough, T., Dunning, L., Plevin, R., Hollenberg, M. D., Sommerhoff, C. P., McLean, J. S., & Ferrell, W. R. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093807 · Cited by 194
Okada, H., Kikuta, T., Kobayashi, T., Inoue, T., Kanno, Y., Takigawa, M., Sugaya, T., Kopp, J. B., & Suzuki, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004040339 · Cited by 181 · cited 1×
“In addition to cytokine production, induction of growth factors, such as insulin-like growth factor 1 (IGF-1), hepatocyte growth factor (HGF), transforming growth factor b (TGFb) and connective tissue growth factor (CTGF) in proximal tubules enhances the activation and proliferation of myofibroblasts and collagen depo…”
BackgroundBadeanlou, L., Furlan-Freguia, C., Yang, G., Ruf, W., & Samad, F. (2011) · Nature Medicine · doi:10.1038/nm.2461 · Cited by 168
Taft, J. L., Nolan, C. J., Yeung, S. P., Hewitson, T. D., & Martin, F. I. (1994) · Diabetes · doi:10.2337/diab.43.8.1046 · Cited by 164 · cited 1×
“In fact, renal dysfunction correlates better with tubular and interstitial lesions than with glomerular changes [12].”
BackgroundActivation of Tubular Epithelial Cells in Diabetic Nephropathy
Morcos, M., Sayed, A. A. R., Bierhaus, A., Yard, B., Waldherr, R., Merz, W., Kloeting, I., Schleicher, E., Mentz, S., Abd el Baki, R. F., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3532 · Cited by 157 · cited 2×
“Increased production of reactive oxygen species, pro-inflammatory cytokines and growth factors by resident and infiltrating cells are associated with the development of tubulointerstitial lesions in both clinical and experimental models of DN [3,4,34].”
BackgroundVergnolle, N., Derian, C. K., D’Andrea, M. R., Steinhoff, M., & Andrade-Gordon, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1467 · Cited by 157 · cited 1×
“Several groups have reported the pro-inflammatory effect of PAR4 activation in endothelial cells [44,45], neutrophils [30] and sensory neurons [46], and suggested that PAR-4 may play an important role in the early event of inflammation including leukocyte rolling and adhesion process [30,45,47].”
BackgroundRecent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy
Tesch, G. H., & Lim, A. K. H. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00607.2010 · Cited by 152 · cited 1×
“Increased production of reactive oxygen species, pro-inflammatory cytokines and growth factors by resident and infiltrating cells are associated with the development of tubulointerstitial lesions in both clinical and experimental models of DN [3,4,34].”
BackgroundHamilton, J. R., Frauman, A. G., & Cocks, T. M. (2001) · Circulation Research · doi:10.1161/hh1301.092661 · Cited by 147 · cited 1×
“Several groups have reported the pro-inflammatory effect of PAR4 activation in endothelial cells [44,45], neutrophils [30] and sensory neurons [46], and suggested that PAR-4 may play an important role in the early event of inflammation including leukocyte rolling and adhesion process [30,45,47].”
BackgroundThe Role of Tubulointerstitial Inflammation in the Progression of Chronic Renal Failure
Rodríguez-Iturbe, B., & García García, G. (2010) · Nephron Clinical Practice · doi:10.1159/000314656 · Cited by 140
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing
Chao, J., Shen, B., Gao, L., Xia, C., Bledsoe, G., & Chao, L. (2010) · Biological Chemistry · doi:10.1515/bc.2010.042 · Cited by 115 · cited 1×
“Tissue kallikrein (KLK1), one of the components of KKS, is a serine protease that cleaves low molecular weight kininogen into kinin, which exerts the biological functions through kinin receptor, B1R and B2R signaling [14,15].”
BackgroundBrown, H. J., Lock, H. R., Wolfs, T. G. A. M., Buurman, W. A., Sacks, S. H., & Robson, M. G. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060634 · Cited by 110 · cited 1×
“A recent study also revealed the heterodimerization between PAR-2 and PAR-4 proteins, suggesting the regulatory role of PAR-2 in the membrane trafficking of PAR-4 [48].”
BackgroundThe kallikrein-kinin system in health and in diseases of the kidney
Kakoki, M., & Smithies, O. (2009) · Kidney International · doi:10.1038/ki.2008.647 · Cited by 106 · cited 1×
“Tissue kallikrein (KLK1), one of the components of KKS, is a serine protease that cleaves low molecular weight kininogen into kinin, which exerts the biological functions through kinin receptor, B1R and B2R signaling [14,15].”
BackgroundHoule, S., Papez, M. D., Ferazzini, M., Hollenberg, M. D., & Vergnolle, N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706371 · Cited by 97 · cited 1×
“Interestingly, recent studies from a rat paw inflammation model showed that edema induced by PAR-4 agonist was blocked by B2R antagonist [53], and PAR-4-induced sensitization of rat joint primary afferents involved B2R activation [54], suggesting a crosstalk between PAR-4 and B2R, but the mechanism remains unknown and…”
BackgroundKallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers
Kontos, C. K., & Scorilas, A. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0247 · Cited by 92 · cited 1×
“Differential expression of KLK1 has been identified in several cancers and other diseases [39].”
BackgroundKelso, E. B., Ferrell, W. R., Lockhart, J. C., Elias-Jones, I., Hembrough, T., Dunning, L., Gracie, J. A., & McInnes, I. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22423 · Cited by 88
Grandaliano, G., Pontrelli, P., Cerullo, G., Monno, R., Ranieri, E., Ursi, M., Loverre, A., Gesualdo, L., & Schena, F. P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000080315.37254.a1 · Cited by 82 · cited 3×
“PAR-2 expression was increased in proximal tubuli in IgAN nephropathy [22] and there was an up-regulation of PAR-1 expression in experimental diabetic glomerulosclerosis [23].”
BackgroundTang, S. C. W., Leung, J. C. K., Chan, L. Y. Y., Tsang, A. W. L., & Lai, K. N. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101113 · Cited by 79 · cited 2×
“cultured proximal tubular epithelial cells (PTEC) [9]; and advanced glycated end-products (AGE) and their carbonyl intermediates induce tubular IL-8, ICAM-1 expression via NFkB, ERK1/2 and STAT-1 signal transduction [10,11].”
BackgroundSelf-citationBradykinin and high glucose promote renal tubular inflammation
Tang, S. C. W., Chan, L. Y. Y., Leung, J. C. K., Cheng, A., Chan, K. W., Lan, H. Y., & Lai, K. N. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp599 · Cited by 77 · cited 9×
“Considering that KLK1 expression was induced by HG in cultured PTEC and increased in the proximal tubules of human diabetic kidney tissue [9], we incubated PTEC with recombinant KLK1 and showed that this serine protease caused the activation of p42/44 and p38 MAPK signaling pathways in renal tubular cells and increase…”
BackgroundMethodSelf-citationTriggering of proteinase‐activated receptor 4 leads to joint pain and inflammation in mice
McDougall, J. J., Zhang, C., Cellars, L., Joubert, E., Dixon, C. M., & Vergnolle, N. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24300 · Cited by 75 · cited 1×
“Several groups have reported the pro-inflammatory effect of PAR4 activation in endothelial cells [44,45], neutrophils [30] and sensory neurons [46], and suggested that PAR-4 may play an important role in the early event of inflammation including leukocyte rolling and adhesion process [30,45,47].”
BackgroundChao, J., Yin, H. H., Gao, L., Hagiwara, M., Shen, B., Yang, Z., & Chao, L. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114587 · Cited by 72 · cited 1×
“In most studies, KLK1 targets B2R via the formation of bradykinin (BK) [49] and we previously demonstrated this phenomenon in HG stimulated PTEC [9] although KLK1 was recently shown to directly activate B2R in the absence of kininogen both in vitro [50] and in vivo [51] in other cell types.”
BackgroundHollenberg, M. D., Οικονομοπούλου, Κ., Hansen, K. K., Saifeddine, M., Ramachandran, R., & Diamandis, E. P. (2008) · Biological Chemistry · doi:10.1515/bc.2008.077 · Cited by 68 · cited 13×
“PARs staining were scored on 0–5 scoring system (0= no cortical staining; 1 =, 10% cortical staining; 2 = 10–20% cortical staining; 3 = 20–40% cortical staining; 4 = 40–60% cortical staining; 5 =.60% cortical staining) and were quantified by Image Pro Plus 6.0 software PLOS ONE | www.plosone.org 6 February 2014 | Volu…”
BackgroundInfluentialReversal of Renal Fibrosis, Inflammation, and Glomerular Hypertrophy by Kallikrein Gene Delivery
Bledsoe, G., Shen, B., Yao, Y., Zhang, J. J., Chao, L., & Chao, J. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.545 · Cited by 68 · cited 1×
“Some studies demonstrated a protective effect of KLK1in reducing inflammation, renal fibrosis and glomerular hypertrophy in salt-induced hypertensive rats [36], and improving cardiac function and hypertension in experimental animal models [37,38].”
BackgroundSlofstra, S. H., Bijlsma, M. F., Groot, A. P., Reitsma, P. H., Lindhout, T., ten Cate, H., & Spek, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075440 · Cited by 66 · cited 1×
“Several groups have reported the pro-inflammatory effect of PAR4 activation in endothelial cells [44,45], neutrophils [30] and sensory neurons [46], and suggested that PAR-4 may play an important role in the early event of inflammation including leukocyte rolling and adhesion process [30,45,47].”
BackgroundTargeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy
Tan, Y., Keum, J.-S., Wang, B., McHenry, M. B., Lipsitz, S. R., & Jaffa, A. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00203.2007 · Cited by 61 · cited 1×
“In addition, the deletion of B2R protected against the development of streptozotocin (STZ)-induced DN [17].”
BackgroundRussell, F. A., Veldhoen, V., Tchitchkan, D., & McDougall, J. J. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00486.2009 · Cited by 60
Zhao, C., Wang, P., Xiao, X., Chao, J., Chao, L., Wang, D. W., & Zeldin, D. C. (2003) · Hypertension · doi:10.1161/01.hyp.0000097603.55404.35 · Cited by 58
Gao, L., Chao, L., & Chao, J. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.10.022 · Cited by 57 · cited 12×
“PARs staining were scored on 0–5 scoring system (0= no cortical staining; 1 =, 10% cortical staining; 2 = 10–20% cortical staining; 3 = 20–40% cortical staining; 4 = 40–60% cortical staining; 5 =.60% cortical staining) and were quantified by Image Pro Plus 6.0 software PLOS ONE | www.plosone.org 6 February 2014 | Volu…”
BackgroundInfluentialYao, Y.-Y., Yin, H. H., Shen, B., SMITH, R. S., Liu, Y., Gao, L., Chao, L., & Chao, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn223 · Cited by 57 · cited 1×
“Some studies demonstrated a protective effect of KLK1in reducing inflammation, renal fibrosis and glomerular hypertrophy in salt-induced hypertensive rats [36], and improving cardiac function and hypertension in experimental animal models [37,38].”
BackgroundSuen, J. Y., Gardiner, B., Grimmond, S., & Fairlie, D. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013809 · Cited by 49 · cited 1×
“PAR-2 is a potent pro-inflammatory mediator in keratinocytes [40] and kidney cells [33,41,42].”
BackgroundKobayashi, T., Inoue, T., Okada, H., Kikuta, T., Kanno, Y., Nishida, T., Takigawa, M., Sugaya, T., & Suzuki, H. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0347-x · Cited by 48 · cited 1×
“Cells were lysed with lysis buffer containing protease inhibitor cocktails (Sigma-Aldrich) as described previously [9,24].”
MethodVesey, D. A., Cheung, C. W. Y., Kruger, W. A., Poronnik, P., Gobe, G. C., & Johnson, D. W. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00209.x · Cited by 44 · cited 1×
“Both thrombin and trypsin stimulate pro-inflammatory responses via the activation of PAR in primary culture of human PTEC [41,43], but not all the effects of thrombin could be reproduced by the PAR-1 agonist, implying that other family members may be involved in provoking these inflammatory responses in PTEC.”
BackgroundKallikrein activates bradykinin B2 receptors in absence of kininogen
Biyashev, D., Tan, F., Chen, Z., Zhang, K., Deddish, P. A., Erdös, E. G., & Hecquet, C. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00934.2005 · Cited by 40 · cited 1×
“In most studies, KLK1 targets B2R via the formation of bradykinin (BK) [49] and we previously demonstrated this phenomenon in HG stimulated PTEC [9] although KLK1 was recently shown to directly activate B2R in the absence of kininogen both in vitro [50] and in vivo [51] in other cell types.”
BackgroundGao, L., SMITH, R. S., Chen, L., Chai, K. X., Chao, L., & Chao, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.084 · Cited by 39 · cited 1×
“Recent studies showed that KLK1 can directly stimulate cell proliferation and migration through protease-activated receptors (PARs) [25,26].”
BackgroundDifferential effects of advanced glycation end‐products on renal tubular cell inflammation
Tang, S. C. W., Chan, L. Y. Y., Leung, J. C. K., Cheng, A., Lin, M. Y., Lan, H. Y., & Lai, K. N. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01437.x · Cited by 36 · cited 1×
“cultured proximal tubular epithelial cells (PTEC) [9]; and advanced glycated end-products (AGE) and their carbonyl intermediates induce tubular IL-8, ICAM-1 expression via NFkB, ERK1/2 and STAT-1 signal transduction [10,11].”
BackgroundSelf-citationRoles of Coagulation Pathway and Factor Xa in the Progression of Diabetic Nephropathy in db/db Mice
Sumi, A., Yamanaka-Hanada, N., Bai, F., Makino, T., Mizukami, H., & Ono, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.824 · Cited by 32 · cited 2×
“PAR-2 is a potent pro-inflammatory mediator in keratinocytes [40] and kidney cells [33,41,42].”
BackgroundOrtiz-Stern, A., Deng, X., Smoktunowicz, N. K., Mercer, P. F., & Chambers, R. C. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24061 · Cited by 32
Tang, S. C. W., Chan, L. Y. Y., Leung, J. C. K., Cheng, A. S., Lan, H. Y., & Lai, K. N. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.81 · Cited by 25 · cited 1×
“However, application of B2R blocker, icatibant only partially reduced HG-induced inflammatory responses and protected the diabetic db/db mice from renal damage [9,52].”
BackgroundSelf-citationUp-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis
Sakai, T., Nambu, T., Katoh, M., Uehara, S., Fukuroda, T., & Nishikibe, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.105 · Cited by 24 · cited 2×
“PAR-2 expression was increased in proximal tubuli in IgAN nephropathy [22] and there was an up-regulation of PAR-1 expression in experimental diabetic glomerulosclerosis [23].”
BackgroundProinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation
Vesey, D. A., Kruger, W. A., Poronnik, P., Gobe, G. C., & Johnson, D. W. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00088.2007 · Cited by 24 · cited 2×
“PAR-2 is a potent pro-inflammatory mediator in keratinocytes [40] and kidney cells [33,41,42].”
BackgroundBraga, A. D., Miranda, J. P., Ferreira, G. M., Bilheiro, R. P., Duarte, I. D. G., Francischi, J. N., & Klein, A. (2010) · Pharmacology · doi:10.1159/000319751 · Cited by 15 · cited 1×
“Several groups have reported the pro-inflammatory effect of PAR4 activation in endothelial cells [44,45], neutrophils [30] and sensory neurons [46], and suggested that PAR-4 may play an important role in the early event of inflammation including leukocyte rolling and adhesion process [30,45,47].”
Background
Research works printed but not linked: 1
- Tang SC, Chan LY, Leung JC, Cheng AS, Lan HY, et al.. (2011) Additive renoprotective effects of B2-kinin receptor blocker and PPAR-gamma agonist in uninephrectomized db/db mice. Lab Invest. 21537328 · DOI
Cited by
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Self-citationKallikreins – The melting pot of activity and function
Kalinska, M., Meyer-Hoffert, U., Kantyka, T., & Potempa, J. (2016) · Biochimie · doi:10.1016/j.biochi.2015.09.023 · Cited by 125
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 138
Gut microbial metabolites SCFAs and chronic kidney disease
Meng, H., Wei, W., Zhang, Y., Xiang, Z., Peng, D., Kasimumali, A., & Rong, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04974-6 · Cited by 128
“…a downstream inflammatory cascade [62], activating the transcription factors NF-κB, AP-1, and p53, and promoting pro-inflammatory cytokine and chemokine production [63–65], further exacerbating the inflammatory state and promoting the disease progression of CKD [66] and renal fibrosis [67].”
BackgroundYiu, W. H., Wong, D. W. L., Wu, H., Li, R. X., Yam, I., Chan, L. Y. Y., Leung, J. C. K., Lan, H. Y., Lai, K. N., & Tang, S. C. W. (2015) · Kidney International · doi:10.1038/ki.2015.331 · Cited by 104
Self-citation
Metadata
- Authors
- Yiu, W. H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Chan, K. W., Lan, H. Y., Lai, K. N., & Tang, S. C. W.
- Affiliations
- Queen Mary Hospital (CN)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Tang, Sydney C. W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-21
- Volume
- 9
- Issue
- 2
- Pages
- e88894
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3931644
- OpenAlex
- W2038515422
- Cited by
- 50
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 7 · 2015: 6
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- American Society of Nephrology
- University of Hong Kong
- National Key Research and Development Program of China (2012CB517600, 2012CB517606)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- tissue kallikrein, KLK1, diabetic nephropathy, proximal tubular epithelial cells, PAR4, kallikrein-kinin system, inflammation, high glucose, advanced glycation end products, MAPK signaling, interleukin-8, ICAM-1, interleukin-6, MCP-1, connective tissue growth factor, type IV collagen, renal fibrosis, calcium mobilization, therapeutic target
- MeSH terms
- Analysis of Variance, Calcium, Cells, Cultured, Diabetes Mellitus, Enzyme-Linked Immunosorbent Assay, Epithelial Cells, Humans, Immunohistochemistry, Inflammation, Kidney Tubules, Proximal, Blotting, Western, Signal Transduction, Cytokines, Interleukin-8, DNA Primers, Receptors, Thrombin, Tissue Kallikreins, RNA Interference, RNA, Small Interfering, Receptors, Proteinase-Activated, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.